- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05399056
Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling (ImPReSS-COPD)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) lead to roughly 1.5 million ED visits and 700,000 hospitalizations annually. Recovery is slow and accompanied by high levels of acute care utilization and mortality. Pulmonary Rehabilitation (PR) is a structured program of exercise and self-management support that has been shown to relieve dyspnea and improve quality of life. Clinical guidelines recommend PR for patients with stable COPD and after an exacerbation. Unfortunately, even when referred by physicians, research has shown that few patients who might benefit from PR ever begin treatment.
The primary goal of this project is to identify effective strategies for promoting and sustaining participation in PR. Peer Support involves pairing a patient with a trained peer from a similar background, and facing similar health challenges, who has completed PR. There is a growing body of evidence demonstrating the feasibility, acceptability, and effectiveness of telephonic peer support for chronic disease management. Narrative interventions, or 'Storytelling', are novel approaches for changing attitudes and behaviors of patients that involve creating and disseminating videos narrated by individuals with lived experience with the same condition or facing the same treatment. Storytelling interventions have been shown to help individuals achieve better blood pressure control, and storytelling is being studied in a variety of other clinical contexts.
In the R61 Phase, the investigators will recruit and train a cohort of peer coaches in behavior change techniques, and will recruit a diverse group of storytellers, capture their narratives on video, and create a library of 6-8 powerful stories. The investigators will finalize the protocol, trial infrastructure, and pilot the recruitment strategy. During the R33 Phase, the investigators will recruit 305 adults treated for exacerbation of COPD, and randomize them to 1) Enhanced "Usual Care" (eUC); 2) eUC + Storytelling; or 3) eUC + Peer Support. The investigators will evaluate the effectiveness of each strategy compared to eUC, and to each other, at promoting participation in PR at 6 months.
Using a mixed-methods approach, the investigators will evaluate intervention acceptability, sustainability, and cost, from the perspectives of the patients and peer coaches as well as PR program staff and hospital leadership. This information will be uses to refine the strategies and to disseminate an implementation package that will enable other PR programs to adopt these approaches.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rajashree Kotejoshyer, ScD
- Phone Number: 978-761-8709
- Email: Rajashree.Kotejoshyer@baystatehealth.org
Study Contact Backup
- Name: Jennifer Hazelton
- Phone Number: 978-337-0340
- Email: jennifer.hazelton@umassmed.edu
Study Locations
-
-
Massachusetts
-
Springfield, Massachusetts, United States, 01199
- Recruiting
- Baystate Health
-
Contact:
- Rajashree Kotejoshyer
- Phone Number: 9787618709
- Email: Rajashree.Kotejoshyer@baystatehealth.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 40 years or older
- Received treatment for COPD exacerbation in either inpatient or outpatient setting
- Referred for pulmonary rehabilitation
- Ability to understand and communicate in English
- Willingness to participate in calls with peer coach and to view storytelling videos
- Working phone
Exclusion Criteria:
- Unwilling to attend PR
- Not eligible for PR based on spirometry or other clinical contraindications as determined by PR staff
- Currently enrolled in, or completion of 12 or more sessions of PR in the past
- Comfort measures only or Hospice care
- Resident of long-term care facility
- Unable or unwilling to give informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Enhanced usual care
Enhanced usual care describes a process in which automated surveillance is used to identify individuals experiencing a COPD exacerbation.
This is followed by direct outreach - either through in-person visits while a patient is hospitalized, or by mail and telephone in the outpatient setting, to facilitate referral to PR. Subjects randomized to this arm will be given a pamphlet describing the benefits of PR.
|
|
|
Active Comparator: Enhanced usual care + Storytelling
Subjects randomized to the eUC + Storytelling intervention will view the video narrative(s) of one or more individuals with COPD who has overcome similar barriers and has attended a program of PR.
Subjects will be shown the first chapter of the story immediately after randomization and will receive email and/or text messages to prompt viewing of subsequent chapters at 2 weeks, 1 month, 2 months, 3 months and 5 months.
Emails and text messages will include a link to a REDCap document that contains a set of embedded video clips representing the next chapter in each storyteller's narrative.
|
Video narratives of an individual with lived experience with COPD and Pulmonary Rehabilitation describing their journey through Pulmonary Rehabilitation
|
|
Active Comparator: Enhanced usual care + Peer support
Subjects randomized to the eUC + Peer support intervention will be matched with a peer coach of the same gender, race, and approximate age.
For those enrolled during a hospitalization, coaches will be instructed to attempt the initial phone contact prior to the patient's discharge; for patients enrolled after an ED visit or outpatient exacerbation, coaches will be instructed to contact the patients within 72 hours of randomization.
Peer coaches will be asked to complete at least one call each week during months 1-2, biweekly calls during months 3-4, and monthly calls during months 5-6.
Coaches will be asked to follow a conversation guide, provided during the initial training, to structure phone conversations with their paired patient.
|
Telephonic Peer Coaching from an individual with lived experience with COPD and Pulmonary Rehabilitation trained in motivational interviewing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of Pulmonary Rehabilitation (PR) sessions: Completion of ≥6 PR sessions within 6 months of randomization
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Any attendance (yes/no) at PR within 6 months of randomization.
Time Frame: 6 months
|
6 months
|
|
Total number of PR sessions completed within 6 months of randomization.
Time Frame: 6 months
|
6 months
|
|
Time to first PR session attended
Time Frame: 6 months
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Modified Medical Research Council (mMRC) dyspnea scale from randomization to 6 months
Time Frame: 6 months
|
6 months
|
|
|
Change in Clinical COPD Questionnaire (CCQ) from randomization to 6 months
Time Frame: 6 months
|
6 months
|
|
|
Change in Hospital Anxiety and Depression Scale (HADS) from randomization to 6 months
Time Frame: 6 months
|
6 months
|
|
|
Activation (Self Efficacy for Managing Chronic Diseases 6)
Time Frame: 6 months
|
6 months
|
|
|
Change in Medical Outcomes Survey (MOS) Social Support Survey from randomization to 6 months
Time Frame: 6 months
|
6 months
|
|
|
Change in UCLA Loneliness Scale from randomization to 6 months
Time Frame: 6 months
|
6 months
|
|
|
Total # of COPD Exacerbations
Time Frame: 6 months
|
6 months
|
|
|
Total # of ED visits
Time Frame: 6 months
|
6 months
|
|
|
Total # of Hospitalizations
Time Frame: 6 months
|
6 months
|
|
|
Change in Modified Medical Research Council (mMRC) dyspnea scale from enrollment to 12 months - For Peer Coach subjects
Time Frame: 12 months
|
12 months
|
|
|
Change in Clinical COPD Questionnaire (CCQ) from enrollment to 12 months- For Peer Coach subjects
Time Frame: 12 months
|
12 months
|
|
|
Change in Activation (Self Efficacy for Managing Chronic Diseases 6) from enrollment to 12 months - For Peer Coach subjects
Time Frame: 12 months
|
12 months
|
|
|
Change in Hospital Anxiety and Depression Scale (HADS) from enrollment to 12 months - For Peer Coach subjects
Time Frame: 12 months
|
12 months
|
|
|
Change in UCLA Loneliness Scale from enrollment to 12 months - For Peer Coach subjects
Time Frame: 12 months
|
12 months
|
|
|
Change in Satisfaction with life scale (SWLS) from enrollment to 12 months - For Peer Coach subjects
Time Frame: 12 months
|
12 months
|
|
|
Breathlessness belief questionnaire
Time Frame: 6-months.
|
11-item scale to measure activity avoidance due to dyspnea.
|
6-months.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Peter Lindenauer, MD, MSc, Baystate Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1730517
- R33HL157847 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.